Clinical Trial Update: Reduced Exposure Study in Smokers Using the Tobacco Heating System 2.2 (THS 2.2) for 5 Days in a Confinement Setting [NA]

View source ↗

Summary

A completed clinical trial evaluating reduced exposure with the Tobacco Heating System 2.2 in smokers over 5 days in confinement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Drugs mentioned

• Tobacco Heating System 2.2

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2016-10-17